199 related articles for article (PubMed ID: 37836779)
1. Synthesis, Anticancer Activity, and In Silico Studies of 5-(3-Bromophenyl)-
Ahsan MJ; Gautam K; Ali A; Ali A; Altamimi ASA; Salahuddin ; Alossaimi MA; Lakshmi SVVNSM; Ahsan MF
Molecules; 2023 Oct; 28(19):. PubMed ID: 37836779
[TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis, ADME, and Anticancer Studies of Newer
Agarwal M; Afzal O; Salahuddin ; Altamimi ASA; Alamri MA; Alossaimi MA; Sharma V; Ahsan MJ
ACS Omega; 2023 Aug; 8(30):26837-26849. PubMed ID: 37593245
[TBL] [Abstract][Full Text] [Related]
3. An Efficient Synthesis of 1-(1,3-Dioxoisoindolin-2-yl)-3-aryl Urea Analogs as Anticancer and Antioxidant Agents: An Insight into Experimental and
Afzal O; Ahsan MJ
Molecules; 2023 Dec; 29(1):. PubMed ID: 38202650
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Anticancer Evaluation of 4-Chloro-2-((5-aryl-1,3,4-oxadiazol-2-yl)amino)phenol Analogues: An Insight into Experimental and Theoretical Studies.
Afzal O; Ali A; Ali A; Altamimi ASA; Alossaimi MA; Bakht MA; Salahuddin ; Alamri MA; Ahsan MF; Ahsan MJ
Molecules; 2023 Aug; 28(16):. PubMed ID: 37630338
[TBL] [Abstract][Full Text] [Related]
6. (E)-N-Aryl-2-oxo-2-(3,4,5-trimethoxyphenyl)acetohydrazonoyl cyanides as tubulin polymerization inhibitors: Structure-based bioisosterism design, synthesis, biological evaluation, molecular docking and in silico ADME prediction.
Wang G; Peng Z; Peng S; Qiu J; Li Y; Lan Y
Bioorg Med Chem Lett; 2018 Nov; 28(20):3350-3355. PubMed ID: 30197030
[TBL] [Abstract][Full Text] [Related]
7. Hydrazide-hydrazones as Small Molecule Tropomyosin Receptor Kina se A (TRKA) Inhibitors: Synthesis, Anticancer Activities,
Alam MS; Lee DU
Med Chem; 2022; 19(1):47-63. PubMed ID: 35490310
[TBL] [Abstract][Full Text] [Related]
8. New Indazol-Pyrimidine-Based Derivatives as Selective Anticancer Agents: Design, Synthesis, and In Silico Studies.
Al-Tuwaijri HM; Al-Abdullah ES; El-Rashedy AA; Ansari SA; Almomen A; Alshibl HM; Haiba ME; Alkahtani HM
Molecules; 2023 Apr; 28(9):. PubMed ID: 37175074
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, anticancer activity and molecular docking studies on a series of heterocyclic trans-cyanocombretastatin analogues as antitubulin agents.
Penthala NR; Zong H; Ketkar A; Madadi NR; Janganati V; Eoff RL; Guzman ML; Crooks PA
Eur J Med Chem; 2015 Mar; 92():212-20. PubMed ID: 25557492
[TBL] [Abstract][Full Text] [Related]
10. Design and discovery of new antiproliferative 1,2,4-triazin-3(2H)-ones as tubulin polymerization inhibitors targeting colchicine binding site.
Eissa IH; Dahab MA; Ibrahim MK; Alsaif NA; Alanazi AZ; Eissa SI; Mehany ABM; Beauchemin AM
Bioorg Chem; 2021 Jul; 112():104965. PubMed ID: 34020238
[TBL] [Abstract][Full Text] [Related]
11. Molecular Docking and In Vitro Anticancer Screening of Synthesized Arylthiazole linked 2H-indol-2-one Derivatives as VEGFR-2 Kinase Inhibitors.
Shalmali N; Bawa S; Ali MR; Kalra S; Kumar R; Zeya B; Rizvi MA; Partap S; Husain A
Anticancer Agents Med Chem; 2022; 22(11):2166-2180. PubMed ID: 34792005
[TBL] [Abstract][Full Text] [Related]
12. 2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibition.
Romagnoli R; Kimatrai Salvador M; Schiaffino Ortega S; Baraldi PG; Oliva P; Baraldi S; Lopez-Cara LC; Brancale A; Ferla S; Hamel E; Balzarini J; Liekens S; Mattiuzzo E; Basso G; Viola G
Eur J Med Chem; 2018 Jan; 143():683-698. PubMed ID: 29220790
[TBL] [Abstract][Full Text] [Related]
13. Green Synthesis of Oxoquinoline-1(2H)-Carboxamide as Antiproliferative and Antioxidant Agents: An Experimental and In-Silico Approach to High Altitude Related Disorders.
Ali A; Ali A; Warsi MH; Rahman MA; Ahsan MJ; Azam F
Molecules; 2022 Jan; 27(1):. PubMed ID: 35011539
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of N-((1-benzyl-1H-1,2,3-triazol-4-yl)methyl)nicotinamides as potential anticancer agents that inhibit tubulin polymerization.
Kamal A; Reddy NV; Nayak VL; Bolla NR; Subba Rao AV; Prasad B
Bioorg Med Chem; 2014 Jul; 22(13):3465-77. PubMed ID: 24835786
[TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis, and Anti-tumor Activity of Novel 2-Aryl Benzimidazole Compounds.
Xiaohelaiti H; Wu W; Gao Y; Li S; Ma C
Anticancer Agents Med Chem; 2023; 23(14):1644-1651. PubMed ID: 37055901
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
[TBL] [Abstract][Full Text] [Related]
17. Dexibuprofen amide derivatives as potential anticancer agents: synthesis, in silico docking, bioevaluation, and molecular dynamic simulation.
Ashraf Z; Mahmood T; Hassan M; Afzal S; Rafique H; Afzal K; Latip J
Drug Des Devel Ther; 2019; 13():1643-1657. PubMed ID: 31190743
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis,
Hussein SAA; Kubba A; Balakit AA; Tahtamouni LH; Abbas AH
Med Chem; 2023; 19(10):1018-1036. PubMed ID: 37259214
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and characterization of novel combretastatin analogues of 1,1-diaryl vinyl sulfones, with antiproliferative potential via in-silico and in-vitro studies.
Egharevba GO; Kamal A; Dosumu OO; Routhu S; Fadare OA; Oguntoye SO; Njinga SN; Oluyori AP
Sci Rep; 2022 Feb; 12(1):1901. PubMed ID: 35115623
[TBL] [Abstract][Full Text] [Related]
20. Distinct Mechanisms of Cytotoxicity in Novel Nitrogenous Heterocycles: Future Directions for a New Anti-Cancer Agent.
Suliman RS; Alghamdi SS; Ali R; Rahman I; Alqahtani T; Frah IK; Aljatli DA; Huwaizi S; Algheribe S; Alehaideb Z; Islam I
Molecules; 2022 Apr; 27(8):. PubMed ID: 35458609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
